These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8042911)

  • 21. Cerebrospinal fluid vasopressin--changes in depression.
    Gjerris A; Hammer M; Vendsborg P; Christensen NJ; Rafaelsen OJ
    Br J Psychiatry; 1985 Dec; 147():696-701. PubMed ID: 3938307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression.
    Kirkegaard C; Faber J; Hummer L; Rogowski P
    Psychoneuroendocrinology; 1979 Jul; 4(3):227-35. PubMed ID: 117477
    [No Abstract]   [Full Text] [Related]  

  • 23. The diurnal variation of immunoreactive thyrotropin-releasing hormone and somatostatin in the cerebrospinal fluid of the rhesus monkey.
    Berelowitz M; Perlow MJ; Hoffman HJ; Frohman LA
    Endocrinology; 1981 Dec; 109(6):2102-9. PubMed ID: 6118259
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid.
    Post RM; Ballenger JC; Hare TA; Bunney WE
    Neurology; 1980 Sep; 30(9):1008-11. PubMed ID: 7191529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid thyrotropin-releasing hormone concentrations in patients with anxiety disorders.
    Fossey MD; Lydiard RB; Ballenger JC; Laraia MT; Bissette G; Nemeroff CB
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):335-7. PubMed ID: 8369645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free thyroxine and 3,3',5'-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression.
    Kirkegaard C; Faber J
    Acta Endocrinol (Copenh); 1991 Feb; 124(2):166-72. PubMed ID: 1900653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contingent tolerance to carbamazepine: alterations in TRH mRNA and TRH receptor binding in limbic structures.
    Rosen JB; Weiss SR; Post RM
    Brain Res; 1994 Jul; 651(1-2):252-60. PubMed ID: 7922572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved.
    Surks MI; DeFesi CR
    JAMA; 1996 May; 275(19):1495-8. PubMed ID: 8622224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyrotropin-releasing hormone (TRH): Measurements in human spinal fluid.
    Shambaugh GE; Wilber JF; Montoya E; Ruder H; Blonsky ER
    J Clin Endocrinol Metab; 1975 Jul; 41(1):131-4. PubMed ID: 807591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid neuropeptides in dementia.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Biol Psychiatry; 1992 Sep; 32(5):452-6. PubMed ID: 1486150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response.
    Post RM; Uhde TW; Ballenger JC; Chatterji DC; Greene RF; Bunney WE
    Arch Gen Psychiatry; 1983 Jun; 40(6):673-6. PubMed ID: 6847334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters.
    Jokinen J; Samuelsson M; Nordström AL; Nordström P
    J Affect Disord; 2008 Nov; 111(1):119-24. PubMed ID: 18342374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increases in thyrotropin-releasing hormone messenger RNA expression induced by a model of human temporal lobe epilepsy: effect of partial and complete kindling.
    Knoblach SM; Kubek MJ
    Neuroscience; 1997 Jan; 76(1):85-95. PubMed ID: 8971761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrotropin-releasing hormone and cyclo (His-Pro)-like immunoreactivities in the cerebrospinal fluids of 'normal' infants and adults, and patients with various neuropsychiatric and neurologic disorders.
    Iriuchijima T; Prasad C; Wilber JF; Jayaraman A; Rao JK; Robertson HJ; Rogers DJ
    Life Sci; 1987 Nov; 41(22):2419-28. PubMed ID: 2891013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid function and affective illness: a reappraisal.
    Joffe RT; Roy-Byrne PP; Udhe TW; Post RM
    Biol Psychiatry; 1984 Dec; 19(12):1685-91. PubMed ID: 6440600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness.
    Post RM; Ballenger JC; Uhde TW; Smith C; Rubinow DR; Bunney WE
    Biol Psychiatry; 1982 Sep; 17(9):1037-45. PubMed ID: 6291645
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotropin and prolactin response to intraspinal TRH administration in man.
    Vigneri R; Pezzino V; Filetti S; Squatrito S; Corso A; Maricchiolo M; Polosa P; Scapagnini U
    Neuroendocrinology; 1977; 23(3):171-80. PubMed ID: 408727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cholinergic system participates in thyrotropin-releasing hormone (TRH) regulation.
    Garcia SI; Pirola CJ; Dabsys SM; Santajuliana D; Delorenzi A; Finkielman S; Nahmod VE
    Neurosci Lett; 1992 Feb; 135(2):193-5. PubMed ID: 1625794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.